GCIA
KYTH

Gabelli & Co Investment Advisers’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-289,545
Closed -$21.7M – 226
2015
Q3 		$21.7M Buy
289,545
+185,207
+178% +$13.8M 3.06% 9
2015
Q2 		$7.86M Buy
+104,338
New +$5.59M 1.13% 24

Gabelli & Co Investment Advisers's KYTH Position: Q4 2015 in Review

Gabelli & Co Investment Advisers sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 289,545 shares — an estimated $21.7M sold.

Gabelli & Co Investment Advisers first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $21.7M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Gabelli & Co Investment Advisers reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 289,545 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $21.7M.
  • Gabelli & Co Investment Advisers first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • Gabelli & Co Investment Advisers's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $21.7M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2015, filed 5 Feb 2016.